ProACT for Treatment of Male SUI
Several groups worldwide have included ProACT implantation in their armamentarium to treat male incontinence. The success rate varies from 56 to 92%. However, it is important to note that EBRT is a contraindication for ProACT implantation and that transurethral manipulations or urethral fibrosis may cause less favorable outcomes. The reoperation rate is significant, but the character of complications (balloon rupture, migration, port infection) is mild. The minimal invasivity and good results when well indicated have led to a constant use of this product over more than a decade, while many other products have been introduced, but soon after left the market.
- 2.Gregori A, Simonato A, Lissiani A, Scieri F, Rossi R, Gaboardi F. Transrectal ultrasound guided implantation of the ProACT adjustable continence therapy system in patients with post-radical prostatectomy stress urinary incontinence: a pilot study. J Urol. 2006;176(51):2109–13.CrossRefPubMedGoogle Scholar
- 3.Gregori A, Romano AL, Scieri F, Pietroantuono F, Incarbone GP, Salvaggio A, Granata A, Gaboardi F. Transrectal ultrasound-guided implantation of adjustable continence therapy (ProACT): surgical technique and clinical results after a mean follow-up of 2 years. Euro Urol. 2010;57(3):430–6.CrossRefGoogle Scholar
- 10.Garcia Matres MJ, Cansino Alcaide JR, Monasterio S, Rodriguez de Bethencourt F, Hidalgo Togores L, de la Pena Barthel J. Paraurethral adjustable continence therapy device (Pro-ACT) in the treatment of urinary incontinence after prostatic surgery. Arch Esp Urol. 2009;62(10):871–81.CrossRefPubMedGoogle Scholar